Patent directory · USPTO A61K / A61P
Patents matching “treatment”
2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 20260146049
SPIROCYCLIC ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER
granted -
US 20260097057
COMBINATION OF ZIBOTENTAN AND DAPAGLIFLOZIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE AND LIVER FIBROSIS
granted -
US 20260083736
GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS FOR USE IN THE TREATMENT OF SUBSTANCE USE DISORDER IN PATIENTS WITH HIGH IMPULSIVITY
granted -
US 20260060930
New crystalline Forms, new pharmaceutical Composition and Dose Regimen of a Dipeptidyl peptidase I inhibitor for the Treatment of Patients with Bronchiectasis or other DPP-I mediated Diseases
granted -
US 20260034134
TREATMENT OF CANCER WITH METASTASES IN THE CENTRAL NERVOUS SYSTEM
granted -
US 12533358
Methods of treatment with elinzanetant
granted -
US 2025388678
Methods, Combinations, and Uses for the Treatment of Muscle Invasive Bladder Cancer
granted -
AU 2025242171
A Medicament and Method of Treatment of Central Nervous System and/or Neuropsychiatric Disorders
granted -
AU 2024276234
METHODS OF TREATMENT USING ANTI-C-MET ANTIBODY DRUG CONJUGATES
granted -
US 2025325692
METHODS OF TREATMENT USING ANTI-SEZ6 ANTIBODY DRUG CONJUGATES
granted -
US 12427155
Treatment for tau-related diseases
granted -
US 12427148
Cancer treatment targeted to tumor adaptive responses to protein synthesis stress
granted -
US 12427160
Use of cannabinoids in the treatment of epilepsy
granted -
US 12421282
Compositions and methods for the treatment of metabolic and liver disorders
granted -
US 12414963
Treatment of sleep-wake disorders and neurodegenerative disease comprising modified resistant maltodextrin
granted -
US 12414995
Bifunctional compounds comprising Apcin-A and their use in the treatment of cancer
granted -
US 12415843
Antibody-interferon fusion proteins for enhancing adoptive T cell therapies for the treatment of cancer
granted -
US 2025281584
ACTIVE VACCINATION FOR THE TREATMENT OF NGF-RELATED DISORDERS
granted -
US 12409205
Nanomolecules for the treatment of inflammatory bowel diseases
granted -
US 12410240
Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infection
granted -
US 12410259
CD47 targeted therapies for the treatment of infectious disease
granted -
US 12410232
Treatment of a canine CD20 positive disease or condition using a canine CD20-specific chimeric antigen receptor
granted -
US 12409224
Compositions and methods for the treatment of VEN/AZA resistant acute myeloid leukemia
granted -
US 12409181
Treatment for aortic aneurysms
granted